Switch to
View more

Rainbow Children's Medicare Ltd

RAINBOW
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹4,664 cr, stock is ranked 499
Moderate RiskStock is 2.65x as volatile as Nifty
459.556.30 (+1.39%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹4,664 cr, stock is ranked 499
Moderate RiskStock is 2.65x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
33.73
PB RatioPB Ratio
10.40
Dividend YieldDiv. Yield
0.38%
Sector PESector PE
32.85
Sector PBSector PB
4.55
Sector Div YldSctr Div Yld
0.97%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Rainbow Children’s Medicare is engaged in the business of rendering medical and healthcare services. The Company is a multi-specialty pediatric, and obstetrics and gynecology hospitals.

Investor PresentationView older 

May 27, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2019202020212022551.14729.74660.31992.7044.5955.7440.02138.28
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 13.87%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

General updates 
Announced OnJun 10, 2022

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015, this is to inform you that Dr. Rohit Manipal Bhojaraj, Group Chief Operating Officer, has tendered his resignation owing to personal reasons, the company has accepted his resignation, which will be effective from close of business hours on June 15, 2022.The handing over process is underway and the company has already initiated the process to identify a replacement.In the interim, till a replacement assumes the role, Dr. Ramesh Kancharla, Chairman and Managing Director and Dr. Dinesh Kumar Chirla, Whole Time Director, would be handling the responsibilities of the Group Chief Operating Officer and there would be no disruption in the functioning of the organization.We request you to kindly take the same on record. | Download

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015, this is to inform you that Dr. Rohit Manipal Bhojaraj, Group Chief Operating Officer, has tendered his resignation owing to personal reasons, the company has accepted his resignation, which will be effective from close of business hours on June 15, 2022.The handing over process is underway and the company has already initiated the process to identify a replacement.In the interim, till a replacement assumes the role, Dr. Ramesh Kancharla, Chairman and Managing Director and Dr. Dinesh Kumar Chirla, Whole Time Director, would be handling the responsibilities of the Group Chief Operating Officer and there would be no disruption in the functioning of the organization.We request you to kindly take the same on record. | Download

Related Party Transaction 
Announced OnJun 9, 2022

Please find the enclosed herewith Related Party Transactions of the Company for the half year ended March 31, 2022. | Download

Please find the enclosed herewith Related Party Transactions of the Company for the half year ended March 31, 2022. | Download

Transcript of Analysts/Institutional Investor Meet/Con. Call 
Announced OnJun 3, 2022

Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015, please find attached herewith Financial Results Webcast Transcript of the Company for Q4 & FY22. | Download

Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015, please find attached herewith Financial Results Webcast Transcript of the Company for Q4 & FY22. | Download

See all events